|
|
Targeting AbcA1 and Ldlr production for the Discoveryof Alzheimers disease Drugs |
| 1R16GM145547-01 |
|
NIGMS |
2022 |
|
|
Regulation of microRNA-218 by TRIM9 in Alzheimers Disease and relhttps://apps.era.nih.gov/gmii/manage/view.era?applId=10497234#ated dementia |
| 3R35GM128753-05S1 |
|
NIGMS |
2022 |
|
|
Investigating structural heterogeneities in amyloid aggregates with multiscale infrared spectroscopic imaging |
| 3R35GM138162-03S1 |
|
NIGMS |
2022 |
|
|
Identification of novel methylation biomarkers in Alzheimers Disease |
| 5P20GM121325-05 |
|
NIGMS |
2022 |
|
|
Optical Imaging Tools for Elucidating the Roles of Anions and Anionic Modifications in Cellular Signaling |
| 5R35GM128923-05 |
|
NIGMS |
2022 |
|
|
Spatial control of membrane traffic by septin GTPases |
| 5R35GM136337-03 |
|
NIGMS |
2022 |
|
|
Investigating structural heterogeneities in amyloid aggregates with multiscale infrared spectroscopic imaging |
| 5R35GM138162-03 |
|
NIGMS |
2022 |
|
|
Development of a Quantitative Iron Characterization System for Alzheimers Disease Using Computed Laminography X-ray Fluorescence Imaging (CL-XRFI) |
| 5R44GM137743-03 |
|
NIGMS |
2022 |
|
|
Single molecules with multi-mechanistic modes of action as probative anti-Alzheimer’s agents |
| 5SC3GM140980-02 |
|
NIGMS |
2022 |
|
|
Single molecules with multi-mechanistic modes of action as probative anti-Alzheimer’s agents |
| 1 SC3 GM140980-01 |
SIKAZWE, DONALD M |
NIGMS |
2021 |